Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Kidney disease, a silent threat, often goes unnoticed due to its subtle symptoms that mimic other common conditions.

Despite their devastating global impact, chronic respiratory diseases remain a hidden threat in low- and middle-income ...

Soligenix's HyBryte (synthetic hypericin) offers a promising solution as a potential first-line therapy for early-stage CTCL. By addressing this critical gap in care, HyBryte has the potential to ...

A 58-year-old man presents for a routine annual physical. During the exam, he mentions an intermittent sensation like a “rush of anxiety” that begins in the abdomen and chest and radiates to the head.

As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that ...

These four very safe dividend stocks from the Goldman Sachs Conviction list may be good ideas for what could be a volatile ...

A new editorial published in Comprehensive Physiology underscores the critical importance of understanding heart-lung interactions in pulmonary ...

We sifted through the Finviz stock screener to compile a list of the top 10 biotech stocks with an upside potential of over ...

BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate ...

Researchers have now found that those with the poorest sleep rhythms may face a 2.8-times-higher risk of Parkinson's disease, ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...